1. Home
  2. MNKD vs NG Comparison

MNKD vs NG Comparison

Compare MNKD & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NG
  • Stock Information
  • Founded
  • MNKD 1991
  • NG 1984
  • Country
  • MNKD United States
  • NG Canada
  • Employees
  • MNKD N/A
  • NG N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • MNKD Health Care
  • NG Basic Materials
  • Exchange
  • MNKD Nasdaq
  • NG Nasdaq
  • Market Cap
  • MNKD 1.7B
  • NG 1.5B
  • IPO Year
  • MNKD 2004
  • NG N/A
  • Fundamental
  • Price
  • MNKD $5.72
  • NG $10.14
  • Analyst Decision
  • MNKD Strong Buy
  • NG Strong Buy
  • Analyst Count
  • MNKD 5
  • NG 3
  • Target Price
  • MNKD $10.80
  • NG $8.33
  • AVG Volume (30 Days)
  • MNKD 3.8M
  • NG 4.8M
  • Earning Date
  • MNKD 11-06-2025
  • NG 10-01-2025
  • Dividend Yield
  • MNKD N/A
  • NG N/A
  • EPS Growth
  • MNKD 149.32
  • NG N/A
  • EPS
  • MNKD 0.11
  • NG N/A
  • Revenue
  • MNKD $301,736,000.00
  • NG N/A
  • Revenue This Year
  • MNKD $16.36
  • NG N/A
  • Revenue Next Year
  • MNKD $20.34
  • NG N/A
  • P/E Ratio
  • MNKD $52.68
  • NG N/A
  • Revenue Growth
  • MNKD 21.48
  • NG N/A
  • 52 Week Low
  • MNKD $3.38
  • NG $2.26
  • 52 Week High
  • MNKD $7.63
  • NG $10.44
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 63.58
  • NG 89.94
  • Support Level
  • MNKD $5.33
  • NG $7.60
  • Resistance Level
  • MNKD $5.90
  • NG $10.34
  • Average True Range (ATR)
  • MNKD 0.21
  • NG 0.38
  • MACD
  • MNKD -0.02
  • NG 0.23
  • Stochastic Oscillator
  • MNKD 77.46
  • NG 91.34

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

Share on Social Networks: